AstraZeneca: all 4,196 studies
Page 3 of 42. Open to participants first (299), then studies with results posted, then the rest; newest registration first within each.
- NIS to Examine the Effectiveness and Safety of Durvalumab and Olaparib in Patients With Endometrial Cancer (DUOLife)RecruitingNCT06890273
- A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)RecruitingNCT06883305Phase 3
- A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate CancerRecruitingNCT06879041Phase 1
- A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)RecruitingNCT06878261Phase 3
- A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung CancerRecruitingNCT06868277Phase 3
- A Multicentre, Single Arm, Non-interventional, Real-world Study to Assess Demographic Characteristics and Patient Reported Outcomes in Patients With Severe Eosinophilic Asthma Treated With Benralizumab in ChinaRecruitingNCT06862206
- REBECCA Real-world Early BrEast CanCer mAnagementRecruitingNCT06856343
- Multinational Observational Study to Describe Diagnostic Stage Shift in Patients With Lung Cancer Using Medical RecordsNot yet recruitingNCT06842056
- Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney TransplantationRecruitingNCT06830798Phase 3
- The Anifrolumab PRIM ProgramRecruitingNCT06795893
- First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid TumoursRecruitingNCT06795022Phase 1/2
- Study That Will Evaluate the Brazilian Population With COPD.RecruitingNCT06780046
- A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric CancerRecruitingNCT06764875Phase 3
- A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood PressureRecruitingNCT06742723Phase 3
- Real-world Study of Trastuzumab Deruxtecan in Patients With Unresectable or Metastatic HER2-low Breast CancerRecruitingNCT06727227
- UmbREALung - A Retrospective and Prospective, Observational, Real World Multi-cohort Study of Patients With Non-small Cell Lung Cancer (NSCLC) Initiating Approved Drugs Developed by AZ or as Part of an AZ AllianceRecruitingNCT06726720
- A Translational Study for Prediction of Biomarkers and Identification of Phenotype and Endotype of COPD and Pre-COPD Outcomes in Chinese PopulationRecruitingNCT06724848
- AZD5305 hADME in Patients With Advanced Solid MalignanciesRecruitingNCT06713369Phase 1
- A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)RecruitingNCT06692738Phase 3
- Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With DapagliflozinRecruitingNCT06677060Phase 3
- Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab UsersRecruitingNCT06659029
- Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart FailureRecruitingNCT06651970Phase 4
- A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLCRecruitingNCT06627647Phase 3
- PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia GravisRecruitingNCT06607627Phase 3
- Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab UsersRecruitingNCT06594068Phase 4
- A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell MalignanciesRecruitingNCT06564038Phase 1/2
- A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma PatientsRecruitingNCT06549595Phase 3
- AQUALIS:QoL of CLL Patients Treated With Acalabrutinib in France, Retrospective Study Based on Data From PLATON DatabaseRecruitingNCT06548152
- Imjudo & Imfinzi PMSRecruitingNCT06544629
- A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.RecruitingNCT06542250Phase 1/2
- Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid TumorsRecruitingNCT06535607Phase 2
- Post-marketing Phase 4 Safety & Tolerability Study of Breztri aerosphereTM in Indian Patients With Chronic Obstructive Pulmonary DiseaseRecruitingNCT06531798Phase 4
- Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHLRecruitingNCT06526793Phase 2
- A Trial to Investigate Benralizumab in Children With Eosinophilic DiseasesRecruitingNCT06512883Phase 3
- NIS to Examine the Effectiveness of TDC in Patients With Metastatic Non-squamous NSCLC and High-risk Genetic AlterationsRecruitingNCT06494540
- RACE-2L: Real-World Assessment of Clinical Practice and Outcomes in Non-squamous NSCLC After Failure of Platinum-based Chemotherapy in BrazilRecruitingNCT06491862
- Clinical and demOgRaphic Features of Patients With Uncontrolled Severe Asthma in Russia (CORSAR)RecruitingNCT06472310
- A Study to Investigate Efficacy and Safety of PT027 Compared With PT007 in Symptomatic Chinese Adults With AsthmaRecruitingNCT06471257Phase 3
- Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract CancerRecruitingNCT06467357Phase 3
- Non-interventional Study of Patients With Transthyretin (ATTR) AmyloidosisRecruitingNCT06465810
- A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)RecruitingNCT06455449Phase 3
- Study of Danicopan as Add-on Treatment to Ravulizumab or Eculizumab in Pediatric Participants With PNH Who Have Clinically Significant Extravascular HemolysisRecruitingNCT06449001Phase 3
- A Non-interventional, Prospective Study With BenralizumabRecruitingNCT06422078
- A Translational Study to Describe Clinical Characteristics, Biomarkers and to Identify Phenotypes and Endotypes Associated With Differential Outcomes in Chinese PopulationRecruitingNCT06419413
- Minimally Interventional Study on Prevalence of Emerging ESR1 Mutations in Liquid Biopsy in Three Cohorts of Patients With Breast Cancer in Comparison With Patient's Baseline ESR1 Mutation Status as Defined by Tissue Profiling.RecruitingNCT06417801
- Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast CancerRecruitingNCT06380751Phase 3
- Lung Cancer Screening Program Using Low-dose Tomography and Metabolomic Evaluation in a Public Service.RecruitingNCT06376097
- Real-World Treatment Study of Koselugo (Selumetinib)RecruitingNCT06360406
- Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic AlterationsRecruitingNCT06357533Phase 3
- OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR AmyloidosisRecruitingNCT06355934
- Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung CancerRecruitingNCT06350097Phase 3
- INTERSTELLAR - International Study Evaluating Lupus Outcomes After Anifrolumab Real World UseRecruitingNCT06314282
- Study of Ultomiris® (Ravulizumab) Safety in PregnancyRecruitingNCT06312644
- Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With AsthmaRecruitingNCT06307665Phase 3
- Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney FunctionRecruitingNCT06307652Phase 3
- A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary DiseaseRecruitingNCT06283966Phase 3
- Study of AZD0754 in Participants With Metastatic Prostate CancerRecruitingNCT06267729Phase 1/2
- Observational Study Protocol: LIVER-RRecruitingNCT06252753
- A Study of GC012F in Patients With Relapsed/Refractory Multiple MyelomaRecruitingNCT06235229Phase 1/2
- AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2RecruitingNCT06219941Phase 2
- LTFU for All Cell and Gene Therapy StudiesNot yet recruitingNCT06194461
- AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.RecruitingNCT06137144Phase 1/2
- AZD0486 as Monotherapy in B-cell Acute Lymphoblastic LeukaemiaRecruitingNCT06137118Phase 1/2
- A Study of AZD3470, a PRMT5 Inhibitor, Given as Monotherapy and in Combination in Patients With MTAP Deficient Advanced/Metastatic Solid TumorsRecruitingNCT06130553Phase 1/2
- A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent ChemoradiotherapyRecruitingNCT06129864Phase 3
- AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple MyelomaRecruitingNCT06106945Phase 1/2
- A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)RecruitingNCT06103864Phase 3
- Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)RecruitingNCT06079671Phase 3
- OSIREAL - Osimertinib RWE on EGFRm NSCLC in SpainRecruitingNCT06068049
- A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe AsthmaRecruitingNCT06023589Phase 3
- Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid TumorsRecruitingNCT06005493Phase 1/2
- PICAROS - Acalabrutinib RWE on 1L CLL in SpainRecruitingNCT05999877
- Danicopan Early Access ProgramAvailableNCT05982938
- Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor TherapiesRecruitingNCT05966467
- Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCLRecruitingNCT05952024Phase 2
- A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H MutationRecruitingNCT05877599Phase 1
- AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)RecruitingNCT05850234Phase 1/2
- An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric ParticipantsRecruitingNCT05835310Phase 3
- Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid TumorsRecruitingNCT05797168Phase 1/2
- A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine TherapyRecruitingNCT05774951Phase 3
- Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaRecruitingNCT05702229Phase 2
- A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering DrugsRecruitingNCT05663515
- Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental OxygenRecruitingNCT05624450Phase 3
- PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive, HER2-low or HER2-ultralow Unresectable or Metastatic Breast Cancer Treated With Trastuzumab DeruxtecanRecruitingNCT05573893
- Observational Study of Acalabrutinib in Patients With Chronic Lymphocytic Leukaemia in the United KingdomRecruitingNCT05557695
- Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)RecruitingNCT05489211Phase 2
- Ondexxya for Intravenous Injection 200mg Drug Use Result Investigation (All Case Investigation)RecruitingNCT05454787
- Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid MalignanciesRecruitingNCT05417594Phase 1/2
- Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With DurvalumabEnrolling by invitationNCT05303532Phase 3
- A Prospective Sub-Study of the Global Hypophosphatasia RegistryRecruitingNCT05234567
- A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid MalignanciesRecruitingNCT05123482Phase 1/2
- Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung CancerRecruitingNCT05061550Phase 2
- Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLCRecruitingNCT04686305Phase 1
- Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)RecruitingNCT04202341
- An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With HyperkalaemiaRecruitingNCT03813407Phase 3
- iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic DiseasesRecruitingNCT03549754
- Registry of Patients With HypophosphatasiaEnrolling by invitationNCT02306720
- Lysosomal Acid Lipase (LAL) Deficiency RegistryRecruitingNCT01633489
- Atypical Hemolytic-Uremic Syndrome (aHUS) RegistryRecruitingNCT01522183
- A Study to Evaluate the Safety, Tolerability, PK, and PD Effects of AZD2389 in Participants With Liver Fibrosis and Compensated Cirrhosis.CompletedNCT06750276Phase 2Results posted